000281536 001__ 281536
000281536 005__ 20251103102758.0
000281536 0247_ $$2doi$$a10.1055/a-2486-6360
000281536 0247_ $$2pmid$$apmid:39824222
000281536 0247_ $$2pmc$$apmc:PMC12483601
000281536 0247_ $$2ISSN$$a0941-3790
000281536 0247_ $$2ISSN$$a0949-7013
000281536 0247_ $$2ISSN$$a1439-4421
000281536 0247_ $$2ISSN$$a1615-5602
000281536 037__ $$aDZNE-2025-01154
000281536 041__ $$aGerman
000281536 082__ $$a610
000281536 1001_ $$aWalendzik, Anke$$b0
000281536 245__ $$aPatient Journey von Menschen mit Down-Syndrom und Demenz: Zugang zur und Schnittstellen in der medizinischen Versorgung – eine qualitative Analyse | Access to and Transitions within the Medical Care Process of Persons with Down Syndrome and Dementia: A Qualitative Analysis
000281536 260__ $$aStuttgart [u.a.]$$bThieme$$c2025
000281536 3367_ $$2DRIVER$$aarticle
000281536 3367_ $$2DataCite$$aOutput Types/Journal article
000281536 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762159957_20023
000281536 3367_ $$2BibTeX$$aARTICLE
000281536 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281536 3367_ $$00$$2EndNote$$aJournal Article
000281536 520__ $$aCompared to the general population, individuals with Down syndrome carry a much higher genetic risk of developing early onset Alzheimer's dementia. This leads to unique challenges and the need for a targeted patient journey.In a qualitative interview study with medical professionals, patient organisations and formal and informal care persons, we assessed barriers within the medical care process of this patient group as well as current approaches to overcome these problems. The study is one module of a multi-method project founded by the Innovation Fund of the German Joint Commission. The results presented here focus on access to and transitions within the medical care process. 14 guided interviews were conducted by a team of moderators by video conference, recorded and transcribed. The analysis of the results was carried out as a qualitative content analysis based on the methods of Mayring.Given the varying degree of premorbid intellectual disability, difficulties recognizing dementia symptoms were reported leading to delays in initiating the diagnostic process. Limited knowledge of the special disease risk and symptom manifestation in routine medical care as well as the lack of specialized medical institutions were identified as additional hurdles. Insufficient dissemination of information about existing specialised institutions to regular physicians and caregivers was criticized. All stakeholder groups drew attention to limitations in access to occupational and speech therapy because of the inadequate number of specialized therapists. Improvements suggested by the interview partners focussed on topics such as the implementation of guidance of the patient journey to and within the medical care process by one institution, easily accessible information for patients and caregivers as well as optimised training for physicians in routine care.Barriers such as insufficient availability of specialised service providers and information deficits about the specific disease risks and symptoms of the population have also been identified in international literatur; in addition, management and coordination deficits in the fragmented German health care system represent well known additional barriers. Approaches to improve the situation can be seen, on the one hand, in improved information and training offers for caregivers and service providers, and, on the other hand, in the expansion of the range of specialized service providers, in particular the Medical Centres for Adults with Disabilities. Informed by these study results and the results of other project modules, health policy recommendations for the improvement of the patient journey of patients with Down syndrome and dementia will be developed in the last project module.
000281536 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000281536 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281536 650_2 $$2MeSH$$aDown Syndrome: epidemiology
000281536 650_2 $$2MeSH$$aDown Syndrome: therapy
000281536 650_2 $$2MeSH$$aDown Syndrome: diagnosis
000281536 650_2 $$2MeSH$$aHumans
000281536 650_2 $$2MeSH$$aGermany: epidemiology
000281536 650_2 $$2MeSH$$aDementia: epidemiology
000281536 650_2 $$2MeSH$$aDementia: therapy
000281536 650_2 $$2MeSH$$aDementia: diagnosis
000281536 650_2 $$2MeSH$$aHealth Services Accessibility: statistics & numerical data
000281536 650_2 $$2MeSH$$aFemale
000281536 650_2 $$2MeSH$$aMale
000281536 650_2 $$2MeSH$$aMiddle Aged
000281536 650_2 $$2MeSH$$aAdult
000281536 650_2 $$2MeSH$$aQualitative Research
000281536 650_2 $$2MeSH$$aAged
000281536 650_2 $$2MeSH$$aTransition to Adult Care: statistics & numerical data
000281536 7001_ $$aWeitzel, Milena$$b1
000281536 7001_ $$aGiebel, Godwin D$$b2
000281536 7001_ $$aRaszke, Pascal$$b3
000281536 7001_ $$aWasem, Jürgen$$b4
000281536 7001_ $$0P:(DE-2719)2811659$$aLevin, Johannes$$b5$$udzne
000281536 7001_ $$0P:(DE-2719)9001249$$aWagemann, Olivia$$b6$$udzne
000281536 7001_ $$aWlasich, Elisabeth$$b7
000281536 7001_ $$0P:(DE-2719)9001761$$aNübling, Georg$$b8$$udzne
000281536 7001_ $$aPantel, Johannes$$b9
000281536 7001_ $$aTesky, Valentina A$$b10
000281536 7001_ $$aSchall, Arthur$$b11
000281536 7001_ $$aHüer, Theresa$$b12
000281536 773__ $$0PERI:(DE-600)2056559-8$$a10.1055/a-2486-6360$$gVol. 87, no. 10, p. 604 - 612$$n10$$p604 - 612$$tDas Gesundheitswesen$$v87$$x0941-3790$$y2025
000281536 8564_ $$uhttps://pub.dzne.de/record/281536/files/DZNE-2025-01154.pdf$$yOpenAccess
000281536 8564_ $$uhttps://pub.dzne.de/record/281536/files/DZNE-2025-01154.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281536 909CO $$ooai:pub.dzne.de:281536$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000281536 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811659$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000281536 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001249$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000281536 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001761$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000281536 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000281536 9141_ $$y2025
000281536 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-28
000281536 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-28
000281536 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aDBCoverage$$bSocial Sciences Citation Index$$d2024-12-28
000281536 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000281536 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bGESUNDHEITSWESEN : 2022$$d2024-12-28
000281536 915__ $$0StatID:(DE-HGF)1180$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences$$d2024-12-28
000281536 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281536 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-28
000281536 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-28
000281536 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-28
000281536 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x0
000281536 9201_ $$0I:(DE-2719)1111016$$kAG Levin$$lClinical Neurodegeneration$$x1
000281536 980__ $$ajournal
000281536 980__ $$aVDB
000281536 980__ $$aUNRESTRICTED
000281536 980__ $$aI:(DE-2719)1111015
000281536 980__ $$aI:(DE-2719)1111016
000281536 9801_ $$aFullTexts